GlassScriptPhysician profile
Hope V Pittman
NPI 1861087215
$3,749.54
in general payments reported to CMS, 2019-2025
39 companies · $1,297 in 2025
The $1,297 reported for 2025 was more than what 90% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $322 · 2022: $551 · 2023: $846 · 2024: $733 · 2025: $1,297.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,599 · Travel and Lodging: $141 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,599.30 |
| Travel and Lodging | $140.93 |
| Education | $135.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $620.48 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $506.05 | 2021-2025 | |
| Janssen Biotech, INC. | $427.92 | 2022-2025 | Erleada |
| Medtronic, INC. | $400.38 | 2025 | Interstim, Intellis Adaptivestim |
| Abbvie INC. | $297.97 | 2021-2025 | |
| Astellas Pharma US INC | $244.31 | 2021-2025 | Xtandi |
| Urovant Sciences INC | $113.08 | 2021-2022 | |
| Tolmar, INC. | $100.23 | 2023-2025 | Eligard, Jatenzo |
| Coloplast Corp | $90.29 | 2022-2025 | Titan |
| Progenics Pharmaceuticals, INC. | $76.31 | 2022-2024 | Pylarify |
| Allergan, INC. | $72.24 | 2021-2022 | |
| Kerecis Limited | $69.42 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Tela Bio, INC. | $67.42 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Urogen Pharma, INC. | $54.00 | 2023-2025 | Jelmyto |
| Accord Healthcare, INC. | $50.00 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mission Pharmacal Company | $47.41 | 2021-2023 | Uribel |
| Hollister Incorporated | $46.50 | 2021-2023 | Infyna Chic |
| Ferring Pharmaceuticals INC. | $36.85 | 2025 | Adstiladrin |
| Hologic Sales and Service, LLC | $34.30 | 2023-2025 | Trident Specimen Radiography System, Trunode, Magseed |
| Pacira Pharmaceuticals Incorporated | $29.53 | 2021-2025 | Iovera, Exparel |
| Boston Scientific Corporation | $28.73 | 2025 | Axonics |
| Tempus Ai, INC | $27.88 | 2024 | |
| Procept Biorobotics Corporation | $24.25 | 2025 | |
| Laborie Medical Technologies Corp. | $23.54 | 2025 | |
| Integra Lifesciences Corporation | $22.20 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Intuitive Surgical, INC. | $21.16 | 2021 | |
| Blue Earth Diagnostics | $20.74 | 2023 | |
| Teleflex LLC | $20.45 | 2025 | Urolift |
| Reprise Biomedical, INC. | $19.98 | 2025 | Miro3d |
| Verity Pharmaceuticals INC. | $18.19 | 2023 | Trelstar |
| Standard Bariatrics, INC. | $17.65 | 2022 | |
| Endo Pharmaceuticals INC. | $16.80 | 2023 | Xiaflex, Aveed |
| Endo USA, INC. | $16.68 | 2025 | Aveed, Xiaflex |
| Asensus Surgical, INC. | $15.79 | 2023 | Senhance |
| Kci USA, INC. | $15.70 | 2023 | Prevena |
| Ethicon US, LLC | $14.26 | 2024 | Certus 140 |
| Alnylam Pharmaceuticals INC. | $13.98 | 2023 | Oxlumo |
| Tolmar Pharmaceuticals, INC. | $13.77 | 2022 | |
| Axonics, INC. | $13.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hope Pittman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.